DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy
- 1 January 1987
- journal article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 32 (2) , 89-106
- https://doi.org/10.1016/0163-7258(87)90054-4
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4′-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)Biochemical and Biophysical Research Communications, 1986
- Novobiocin inhibits RNA polymerase III transcriptionin vitroby a mechanism distinct from DNA topoisomerase IINucleic Acids Research, 1986
- Localization of topoisomerase II in mitotic chromosomes.The Journal of cell biology, 1985
- Topoisomerase II is a structural component of mitotic chromosome scaffolds.The Journal of cell biology, 1985
- Novobiocin inhibition of DNA excision repair may occur through effects on mitochondrial structure and ATP metabolism, not on repair topoisomerasesCarcinogenesis: Integrative Cancer Research, 1985
- Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1984
- Chromatin assembly in Xenopus oocytes: In vitro studiesCell, 1984
- Reconstitution of intercalator-induced DNA scission by an active component from nuclear extractsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1983
- N-Trifluoroacetyladriamycin-14-valerate and adriamycin induced DNA damage in the RPMI-6410 human lymphoblastoid cell lineCanadian Journal of Biochemistry, 1980
- DNA Gyrase and the Supercoiling of DNAScience, 1980